- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Sarah Wall: Challenges Faced by Older Patients With Hematologic Disorders
Older patients often face financial challenges on fixed incomes with different payer systems like Medicare, Sarah Wall, MD, The Ohio State University Comprehensive Cancer Center, says. Accessing treatment centers far away is difficult due to support system disruptions, leading to increased stress and financial strain.
In an interview with The American Journal of Managed CareⓇ, Sarah Wall, MD, assistant professor in the Division of Hematology at The Ohio State University Comprehensive Cancer Center, emphasizes the need to study treatments for different age groups, particularly focusing on older adults with hematologic disorders. Even the FDA has stressed this due to disease variations and social dynamics, she explains.
Transcript
What are some unique struggles that older adults with hematologic disorders face?
This is a really important one, and it's one that has had a lot of light shed on it recently by a number of organizations. I think one really important one, in particular, is the FDA has actually issued guidance that it's really important that we study treatments and focusing on those cohorts, in part because of some of the things we just talked about, that the diseases may behave differently.
But there's such a difference in social dynamics and engagement with the environment around them for older adults vs younger adults because the things that may often be overlooked are related to financial toxicity. Finances, for older patients, without making an overgeneralization, finances are often very different for older patients when they may be on a fixed income.
The payers are often very different for older patients when we start getting into Medicare coverage. And then, the other things that come into play that are less tangible, even, are things like where you've set up your support system, and that will differ by family. But a lot of older patients are in a setting where they've got kids or grandkids or lifelong friends and family who are around them and supporting them.
And so depending on how far away they live from a treatment center, having to uproot themselves from all of that support can be very taxing and actually sometimes make it prohibitive to get the best treatment that they could. Then there are costs with all of that, too. Gas money, hotel money, all of those things play a role and those can often be really big stressors when you also add in that piece of potentially going on a fixed income or having to dip into savings that were supposed to last well into retirement.
Integrating RECIST and Clinician Approaches Boosts NSCLC Research
May 8th 2024Outcomes among patients with stage IV non–small cell lung cancer as evaluated within clinical trials via Response Evaluation Criteria in Solid Tumors (RECIST) and clinician response criteria in observational studies were compared for their concordance and reliability.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More
